40.13
price down icon7.19%   -3.11
after-market Handel nachbörslich: 40.11 -0.02 -0.05%
loading

Agios Pharmaceuticals Inc Aktie (AGIO) Neueste Nachrichten

pulisher
Nov 03, 2025

Will Agios Pharmaceuticals Inc. benefit from macro trendsWeekly Volume Report & Real-Time Volume Trigger Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Agios Pharmaceuticals Inc. (8AP) stock correlates with oil marketsRecession Risk & Safe Capital Investment Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Agios (AGIO) Unveils Promising Mitapivat Data at ASH 2025 - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

What data driven models say about Agios Pharmaceuticals Inc.’s futureQuarterly Trade Summary & Daily Entry Point Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Agios (Nasdaq: AGIO) shows mitapivat data: 77.8% alpha-thal response; 30.5-week mean - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Can Agios Pharmaceuticals Inc. stock deliver sustainable ROEShare Buyback & AI Powered Market Entry Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Agios Pharmaceuticals Inc. (8AP) stock a top dividend aristocrat candidateJuly 2025 Breakouts & AI Optimized Trade Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How supply chain issues affect Agios Pharmaceuticals Inc. stockJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Agios Pharmaceuticals Inc. building a consolidation basePortfolio Risk Report & AI Driven Stock Movement Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What is HC Wainwright's Estimate for AGIO FY2025 Earnings? - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

What earnings revisions data tells us about Agios Pharmaceuticals Inc.Entry Point & Smart Investment Allocation Insights - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Agios Pharmaceuticals Inc. stock reach $100 price targetWeekly Trade Review & Reliable Trade Execution Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is it time to cut losses on Agios Pharmaceuticals Inc.Inflation Watch & Breakout Confirmation Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is Agios Pharmaceuticals Inc. stock supported by strong cash flows2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What drives Agios Pharmaceuticals Inc stock priceMarket Capitalization Trends & High Return Capital Strategies - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

Is Agios Pharmaceuticals Inc. (8AP) stock among top earnings playsMarket Volume Summary & Safe Capital Growth Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Institutional scanner results for Agios Pharmaceuticals Inc.Bond Market & Weekly Chart Analysis and Trade Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Savvy Advisors Inc. Takes Position in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 02:45:06 - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Candlestick signals on Agios Pharmaceuticals Inc. stock todayQuarterly Market Summary & Reliable Price Action Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Agios Pharmaceuticals Q3 2025 Earnings Preview - MSN

Nov 01, 2025
pulisher
Nov 01, 2025

Agios outlines Q4 2025 PYRUKYND milestones and anticipates U.S. thalassemia approval amid global expansion - MSN

Nov 01, 2025
pulisher
Nov 01, 2025

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 01, 2025
pulisher
Nov 01, 2025

RBC Capital Keeps Their Buy Rating on Agios Pharma (AGIO) - The Globe and Mail

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 04:26:21 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Agios Pharmaceuticals’ Earnings Call: Growth and Challenges - MSN

Nov 01, 2025
pulisher
Oct 31, 2025

AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues - sharewise.com

Oct 31, 2025
pulisher
Oct 31, 2025

Agios Pharmaceuticals (NASDAQ:AGIO) Issues Quarterly Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat

Oct 31, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):